These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30456543)

  • 1. Antibody-initiated beneficial and harmful immune responses.
    Barabas AZ; Cole CD; Lafreniere R
    Immunol Res; 2018 Dec; 66(6):783-789. PubMed ID: 30456543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified vaccination technique for prophylactic and therapeutic applications to combat endogenous antigen-induced disorders.
    Barabas AZ; Cole CD; Barabas AD; Graeff RM; Lafreniere R; Weir DM
    Scand J Immunol; 2010 Mar; 71(3):125-33. PubMed ID: 20415778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance, loss of tolerance and regaining tolerance to self by immune-mediated events.
    Barabas AZ; Cole CD; Graeff RM; Lafreniere R; Weir DM
    Immunol Res; 2017 Feb; 65(1):402-409. PubMed ID: 27456203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The modified vaccination technique designed to prevent and cure acute and chronic disorders.
    Barabas AZ; Cole CD; Kovacs ZB; Kovacs EI; Lafreniere R; Weir DM
    Hum Antibodies; 2020; 28(2):111-121. PubMed ID: 31594214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified vaccination technique for the prevention and treatment of an experimental autoimmune kidney disease.
    Barabas AZ; Cole CD; Barabas AD; Lafreniere R
    Ann N Y Acad Sci; 2007 Sep; 1110():619-29. PubMed ID: 17911477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correcting autoimmune anomalies in autoimmune disorders by immunological means, employing the modified vaccination technique.
    Barabas AZ; Cole CD; Barabas AD; Graeff RM; Lafreniere R; Weir DM
    Autoimmun Rev; 2009 Jun; 8(7):552-7. PubMed ID: 19393215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of human autoimmunity--autoantibodies versus autoimmune disease.
    Lleo A; Invernizzi P; Gao B; Podda M; Gershwin ME
    Autoimmun Rev; 2010 Mar; 9(5):A259-66. PubMed ID: 19963079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases.
    Marciani DJ
    Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine.
    Belloni C; Avanzini MA; De Silvestri A; Martinetti M; Pasi A; Coslovich E; Autelli M; Masanti ML; Cuccia M; Tinelli C; Rondini G; Lorini R
    Pediatrics; 2002 Jul; 110(1 Pt 1):e4. PubMed ID: 12093985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T and B cell tolerance and responses to viral antigens in transgenic mice: implications for the pathogenesis of autoimmune versus immunopathological disease.
    Zinkernagel RM; Pircher HP; Ohashi P; Oehen S; Odermatt B; Mak T; Arnheiter H; Bürki K; Hengartner H
    Immunol Rev; 1991 Aug; 122():133-71. PubMed ID: 1937540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
    Coutinho A; Caramalho I; Seixas E; Demengeot J
    Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathological events initiated and maintained by pathogenic IgG autoantibodies in an experimental autoimmune kidney disease.
    Barabas AZ; Cole CD; Lafreniere R; Weir DM
    Autoimmunity; 2012 Nov; 45(7):495-509. PubMed ID: 22816962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of autoimmunologists in investigating and treating autoimmune disorders.
    Barabas AZ; Cole CD; Graeff RM; Lafreniere R; Weir DM
    Autoimmun Rev; 2011 Jan; 10(3):166-70. PubMed ID: 20887816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody Production in Cancer--The Humoral Immune Response toward Autologous Antigens in Cancer Patients.
    Zaenker P; Gray ES; Ziman MR
    Autoimmun Rev; 2016 May; 15(5):477-83. PubMed ID: 26827909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity.
    Suurmond J; Diamond B
    J Clin Invest; 2015 Jun; 125(6):2194-202. PubMed ID: 25938780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural human antibodies to synthetic peptide autoantigens: correlations with age and autoimmune disease.
    Marchalonis JJ; Schluter SF; Wilson L; Yocum DE; Boyer JT; Kay MM
    Gerontology; 1993; 39(2):65-79. PubMed ID: 8514202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers, self-antigens and the immunological homunculus.
    Cohen IR
    J Autoimmun; 2007 Dec; 29(4):246-9. PubMed ID: 17888625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New vaccination technology for endogenous antigen-derived ailments.
    Barabas AZ; Cole CD; Barabas AD; Bahlis NJ; Lafreniere R
    IDrugs; 2008 Feb; 11(2):111-5. PubMed ID: 18240096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reparative processes and immunity].
    Babaeva AG
    Izv Akad Nauk Ser Biol; 1999; (3):261-9. PubMed ID: 10441909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amount of self-antigen determines the effector function of murine T cells escaping negative selection.
    Swee LK; Nusser A; Curti M; Kreuzaler M; Rolink H; Terracciano L; Melchers F; Andersson J; Rolink A
    Eur J Immunol; 2014 May; 44(5):1299-312. PubMed ID: 24497074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.